Related Experiment Video
Updated: Sep 19, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetes distress screening using PAID-5 and PAID-1 among adults attending a tertiary multidisciplinary type 1
Jonathan Vu1, Krisha Solanki1, Jenny McKay1
1Department of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia.
Aims:
Living with type 1 diabetes can be challenging, and diabetes distress may be overlooked during time-constrained clinical assessments. Screening for diabetes distress with the one-item Problem Areas in Diabetes Scale (PAID)-1, in conjunction with the five-item PAID-5, may offer an efficient method to improve type 1 diabetes assessment. We aimed to evaluate the utility of this approach to identify possible diabetes distress and its clinically significant covariates.
Methods:
We performed a retrospective, real-world, cross-sectional study of adults attending a multidisciplinary type 1 diabetes outpatient clinic at a tertiary centre from October 2023 to September 2024, inclusive. Screening was conducted using PAID-5 (incorporating PAID-1) during the initial consultation.
Results:
There were 160 adults included (median age 38 years [IQR 30-52]; type 1 diabetes duration 16 years [4-24]; n = 138 [86%] were using continuous glucose monitoring [CGM]). PAID-5 median score was 8 [4-12]; 83 individuals (52%) had a score ≥8, indicating possible diabetes distress. Higher diabetes distress screening scores were associated with CGM metrics indicative of hyperglycaemia; no associations were observed with CGM-detected hypoglycaemia. PAID-1 had sensitivity 81% and specificity 96% for PAID-5-detected diabetes distress.
Conclusions:
A high prevalence of diabetes distress was detected on screening among adults attending a tertiary type 1 diabetes service. This highlights the importance of psychological assessment and implementation of management strategies for diabetes distress to reduce the burden of living with type 1 diabetes. Our findings support the use of the PAID-1 as a rapid screening tool to assess for diabetes distress.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...